Pharmagest Interactive SA Stock Swiss Exchange
Equities
FR0000077687
IT Services & Consulting
End-of-day quote
Other stock markets
|
||
- EUR | - |
May. 08 | Equasens: sales down 5% in Q1 | CF |
Apr. 02 | Equasens : RNPG virtually stable in 2023 | CF |
Sales 2024 * | 226M 245M | Sales 2025 * | 245M 266M | Capitalization | 904M 981M |
---|---|---|---|---|---|
Net income 2024 * | 47M 51.05M | Net income 2025 * | 52M 56.49M | EV / Sales 2024 * | 3.61 x |
Net cash position 2024 * | 90.1M 97.87M | Net cash position 2025 * | 97.97M 106M | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
16.9
x | Employees | - |
Yield 2024 * |
2.22% | Yield 2025 * |
2.42% | Free-Float | 32.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 90-12-31 | |
Thierry Chapusot
FOU | Founder | 65 | 96-01-24 |
Director of Finance/CFO | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Chapusot
FOU | Founder | 65 | 96-01-24 |
Director/Board Member | 46 | 17-06-26 | |
Director/Board Member | 59 | 99-12-31 |
1st Jan change | Capi. | |
---|---|---|
-12.23% | 194B | |
+2.14% | 169B | |
+3.31% | 155B | |
+7.34% | 102B | |
+32.80% | 82.01B | |
+11.06% | 81.78B | |
-6.11% | 72.08B | |
-17.06% | 55.12B | |
-8.44% | 43.73B |